Surgical matrix patches recalled for labeling correction on wound dehiscence management
CorNeat EverPatch permanent tissue-integrating surgical matrices are the subject of a retroactive labeling correction, following complaints, to include prevention and management of wound dehiscence.
The agency’s classification
FDA (Devices): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: Rubric level 2 covers precautionary recalls; the action is a labeling correction rather than a defect described in the product.
Plain-English summary
The CorNeat EverPatch, REF 1036295, a permanent tissue-integrating surgical matrix measuring 5.0 mm by 6.5 mm by 100 microns, sterile EO and prescription only, UDI-DI G16010362950, is being recalled. Distribution was nationwide in the United States and internationally.
The action is retroactive and was taken, following complaints, as a labeling correction for permanent tissue-integrating surgical matrices to include prevention and management of wound dehiscence. The FDA classified the action as Class II. The notice does not describe a defect in the product itself.
Surgical centres holding this product should follow the manufacturer's instructions for applying the updated labeling.
The recalled product
- Product
- CorNeat EverPatch, REF: 1036295, Permanent Tissue-Integrating Surgical Matrix, 5.0 mm x 6.5 mm x 100 um, SterileEO, RX only
- Manufacturer
- CORNEAT VISION, LTD.
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- UDI-DI: G16010362950
Distribution
Related recalls
Same manufacturer · CORNEAT VISION, LTD.
See all →- HighScleral reinforcement matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
- HighOcular surgical matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
Same hazard · labeling correction
See all →- ModerateAbbott Amplatzer Steerable Delivery Sheath instructions for use updated
FDA (Devices) · 2022-04-13
- ModerateHeparin Activity Assay Labeling Correction: Reduced On-Board Stability
FDA (Devices) · 2021-10-27
- ModerateBF-P180 EVIS EXERA II Bronchovideoscope Reprocessing Instructions Validation Recall
FDA (Devices) · 2021-10-06
Similar recalls
- HighOcular surgical matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
- HighScleral reinforcement matrix recalled after complaints of early patch exposure
FDA (Devices) · 2025-10-15
- HighSurgiMend 3.0 Soft Tissue Graft Recalled for Endotoxin Testing Defect
FDA (Devices) · 2023-07-12
- HighSurgical Patties and Strips Recalled for Elevated Endotoxin Levels
FDA (Devices) · 2024-11-06
- HighSurgical Patties and Strips Recalled for Endotoxin Contamination
FDA (Devices) · 2024-11-06
- HighSurgiMend 2.0 Collagen Matrix Recalled for Endotoxin Testing Issues
FDA (Devices) · 2023-07-12